YadavRKKumarDGuptaA, et al.C-reactive protein and procalcitonin: As predictor biomarkers of severity and outcome in children with community-acquired pneumonia. Trop Doct2024 May 2: 494755241250371. DOI:https://doi.org/10.1177/00494755241250371.
2.
WenerMDaumPMcQuillanG. The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol2000; 27: 2351–2359.
3.
ChunKChungWKimAJ, et al.Association between acute kidney injury and serum procalcitonin levels and their diagnostic usefulness in critically ill patients. Sci Rep2019; 9: 4777. https://doi.org/10.1038/s41598-019-41291-1
4.
Silvestre JP daSCoelhoLMdaC,et al.Impact of fulminant hepatic failure in C-reactive protein?J Crit Care2010; 25: 657.e7–657.e12.
MarkandayA. Acute phase reactants in infections: evidence-based review and a guide for clinicians. Open Forum Infect Dis2015; 2: ofv098.
7.
KhilnaniGCTiwariPZirpeKG, et al.Guidelines for the use of procalcitonin for rational use of antibiotics. Indian J Crit Care Med2022; 26: S77–S94.
8.
SalinasMLópez-GarrigósMFloresE, et al.Procalcitonin in the emergency department: a potential expensive over-request that can be modulated through institutional protocols. Am J Emerg Med2018; 36: 158–160.
